Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001415889-25-015985

Options or other derivatives

  • Director acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schoeneck James A Director 2025-06-04 Grant or award · Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X05/form4-06062025_080651.xml…